Skip to main content
. 2011 Oct 19;3(1):61–65. doi: 10.3892/ol.2011.449

Table II.

Patients responding to high-dose toremifene therapy.

Age Response ER/PgR HER2 Duration of AI (months) Disease sites Time to progression (months)
74 Long SD +/− 0 33.5 Chest wall 24.0
58 PR +/− 0 41.0 Liver 10.4
75 Long SD +/− 0 51.5 Lung 14.2
52 Long SD +/− 0 23.7 Liver 9.9
65 Long SD +/− 0 44.5 Lymph node 9.0
66 Long SD +/− 1 39.8 Lung 6.7

SD, stable disease; PR, partial response.